SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma

Clinical and Translational Oncology

Volumn 12, Issue 11, 2010, Pages 760-764

  Rodríguez Abreu, Delvys ^e   Llanos Muñoz, Marta ^a   Provencio Pulla, Mariano ^b   Rueda Domínguez, Antonio ^c   Isla Casado, Dolores ^d  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c HOSPITAL COSTA DEL SOL   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^e NONE

Author keywords

FLIPI; Follicular lymphoma; Guideline; Novel treatments; Rituximab

Indexed keywords

BENDAMUSTINE; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD5 ANTIGEN; CD79A ANTIGEN; CHLORAMBUCIL; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; IBRITUMOMAB TIUXETAN; INTERFERON; LEUKOSIALIN; MITOXANTRONE; PREDNISONE; PROTEIN BCL 2; RITUXIMAB; VINCRISTINE;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; COMPUTER ASSISTED TOMOGRAPHY; FOLLICULAR LYMPHOMA; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PROGRESSION FREE SURVIVAL; REVIEW; TUMOR BIOPSY;

ALGORITHMS; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, NON-HODGKIN; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; SPAIN;

EID: 78649669024     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-010-0592-7     Document Type: Review

References (19)

1. D. Tan S. Horning 2008 Follicular lymphoma: clinical features and treatment Hematol Oncol Clin North Am 22 863 882 10.1016/j.hoc.2008.07.013 18954741
2. Swerdlow SH, Campo E, Harris NL et al (eds) (2008) 4th World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon
3. (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89:3909-3918
4. T.A. Lister D. Crowder S.B. Sutcliffe, et al. 1989 Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's Lymphoma: Costwolds meeting J Clin Oncol 7 1630 1636 1:STN:280: DyaK3c%2FjvFCnsA%3D%3D 2809679
5. P. Solal-Celigny P. Roy M. Dreyling, et al. 2004 The Follicular Lymphoma Prognostic Index (FLIPI) Blood 104 1258 1265 1:CAS:528:DC%2BD2cXnt1ekuro%3D 10.1182/blood-2003-12-4434 15126323 (Pubitemid 39166497)
6. B.A. Guadagnolo S. Li D. Neuberg, et al. 2006 Long-term outcome and mortality trends in earlystage, grade 1-2 follicular lymphoma treated with radiation therapy Int J Radiat Oncol Biol Phys 64 928 934 16243446
7. J.F. Seymour B. Pro L.M. Fuller, et al. 2003 Longterm follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma J Clin Oncol 21 2115 2122 1:CAS:528:DC%2BD2cXpsVGqtb0%3D 10.1200/JCO.2003.07.111 12775737 (Pubitemid 46606360)
8. R. Advani S.A. Rosenberg S.J. Horning 2004 Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy J Clin Oncol 22 1454 1459 10.1200/JCO.2004.10.086 15024027 (Pubitemid 41103628)
9. R.C. Young D.L. Longo E. Glatstein, et al. 1988 The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment Semin Hematol 25 [2Suppl2] 11 16 1:STN:280:DyaL1c3ptVOisw%3D%3D 2456618
10. H. Schulz J. Bohlius N. Skoetz, et al. 2006 Combined immunochemotherapy with rituximab improves overall survival in patients with follicular and mantle cell lymphoma: updated meta-analysis results [Abstract] Blood 108 A 2760
11. K.S. Robinson M.E. Williams R.H. van der Jagt, et al. 2008 Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma J Clin Oncol 26 4473 4479 1:CAS:528:DC%2BD1cXht1ejurzP 10.1200/JCO.2008.17.0001 18626004
12. M. Ghielmini S.F. Schmitz S.B. Cogliatti, et al. 2004 Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule Blood 103 4416 4423 1:CAS:528:DC%2BD2cXlt1KrsLY%3D 10.1182/blood-2003-10-3411 14976046 (Pubitemid 38745964)
13. B.A. Peterson G.R. Petroni G. Frizzera, et al. 2003 Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B J Clin Oncol 21 5 15 1:CAS:528:DC%2BD2cXpsVWru70%3D 10.1200/jco.2003.05.128 12506163
14. L. Vidal A. Gafter-Gvili L. Leibovici, et al. 2009 Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials J Natl Cancer Inst 101 248 255 1:CAS:528:DC%2BD1MXisVSksrg%3D 10.1093/jnci/djn478 19211444
15. F. Morschhauser J. Radford A. Van Hoof, et al. 2008 Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma J Clin Oncol 26 5156 5164 1:CAS:528:DC%2BD1cXhsVyqsrnE 10.1200/JCO.2008.17.2015 18854568
16. A.Z. Rohatiner W.M. Gregory B. Peterson, et al. 2005 Meta-analysis to evaluate the role of interferon in follicular lymphoma J Clin Oncol 23 2215 2223 1:CAS:528:DC%2BD2MXjsVyiu7k%3D 10.1200/JCO.2005.06.146 15684317 (Pubitemid 46218713)
17. M.S. Kaminski J. Estes K.R. Zasadny, et al. 2000 Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience Blood 96 1259 1266 1:CAS:528:DC%2BD3cXlvF2it7k%3D 10942366
18. H.C. Schouten W. Qian S. Kvaloy, et al. 2003 High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial J Clin Oncol 21 3918 3927 1:CAS:528:DC%2BD2cXpsVajsLc%3D 10.1200/JCO.2003.10.023 14517188 (Pubitemid 46606204)
19. M. Dreyling 2009 Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann Oncol 20 119 120 10.1093/annonc/mdp148 19454429